These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35074585)

  • 61. Rapid-acting antidepressants.
    Witkin JM; Martin AE; Golani LK; Xu NZ; Smith JL
    Adv Pharmacol; 2019; 86():47-96. PubMed ID: 31378256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cortical and raphe GABA
    Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
    Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.
    Akinfiresoye L; Tizabi Y
    Psychopharmacology (Berl); 2013 Nov; 230(2):291-8. PubMed ID: 23732839
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.
    Burgdorf J; Kroes RA; Zhang XL; Gross AL; Schmidt M; Weiss C; Disterhoft JF; Burch RM; Stanton PK; Moskal JR
    Behav Brain Res; 2015 Nov; 294():177-85. PubMed ID: 26210936
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.
    Klein ME; Chandra J; Sheriff S; Malinow R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2656-2662. PubMed ID: 31941713
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Convergent Mechanisms Underlying Rapid Antidepressant Action.
    Zanos P; Thompson SM; Duman RS; Zarate CA; Gould TD
    CNS Drugs; 2018 Mar; 32(3):197-227. PubMed ID: 29516301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
    Hashimoto K
    Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Rapid-acting antidepressants-neurobiological mechanisms of action].
    Gass P; Vasilescu AN; Inta D
    Nervenarzt; 2022 Mar; 93(3):223-233. PubMed ID: 34766186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
    Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Engaging homeostatic plasticity to treat depression.
    Workman ER; Niere F; Raab-Graham KF
    Mol Psychiatry; 2018 Jan; 23(1):26-35. PubMed ID: 29133952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
    Khan MA; Houck DR; Gross AL; Zhang XL; Cearley C; Madsen TM; Kroes RA; Stanton PK; Burgdorf J; Moskal JR
    Int J Neuropsychopharmacol; 2018 Mar; 21(3):242-254. PubMed ID: 29099938
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bridging rapid and sustained antidepressant effects of ketamine.
    Kim JW; Suzuki K; Kavalali ET; Monteggia LM
    Trends Mol Med; 2023 May; 29(5):364-375. PubMed ID: 36907686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NMDARs Containing NR2B Subunit Do Not Contribute to the LTP Form of Hippocampal Plasticity: In Vivo Pharmacological Evidence in Rats.
    Ahnaou A; Heleven K; Biermans R; Manyakov NV; Drinkenburg WH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445376
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ifenprodil rapidly ameliorates depressive-like behaviors, activates mTOR signaling and modulates proinflammatory cytokines in the hippocampus of CUMS rats.
    Yao Y; Ju P; Liu H; Wu X; Niu Z; Zhu Y; Zhang C; Fang Y
    Psychopharmacology (Berl); 2020 May; 237(5):1421-1433. PubMed ID: 32130432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Repurposing of Drugs-The Ketamine Story.
    Das J
    J Med Chem; 2020 Nov; 63(22):13514-13525. PubMed ID: 32915563
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Resolvins as novel targets for rapid-acting antidepressants].
    Deyama S
    Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
    Duman RS
    Dialogues Clin Neurosci; 2014 Mar; 16(1):11-27. PubMed ID: 24733968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.